Abstract:Objective To discuss the protection role of mycophenolate mofetil (MMF) on podocyte injury of adriamycin nephropathy (ADN) rats and the effect on expression of miRNAs in renal tissue. Methods Totally 60 healthy male SD rats were randomly divided into CTL group, ADN group and MMF group. SD rats in ADN group and MMF group were injected adriamycin (6.5mg/kg) for building ADN models. After 7d, MMF was administrated orally once a day. The levels of 24-hour urinary protein quantity, blood urea nitrogen (BUN) and serum creatinine (Scr) were measured after 28d. Histopathological changes in renal tissue were graded through H&E, PAS and Masson staining. The differences and expression levels of miRNAs (including miRNAs-23a, miRNAs-300-3p, miRNAs-24 and miRNAs-300-3c) in kidney were measured by a biochip assay and qRT-PCR. Results The weight loss of animals (P < 0.05), the degree of kidney tissue injury (P < 0.05), the apoptosis rate of podocyte (P < 0.05) and the levels of BUN, Scr and urinary protein quantity (P < 0.05) in ADN group were higher than those in CTL group, which were attenuated with treatment of MMF (P < 0.05). The expression of rno-miR-23a and rno-miR-300-3p in ADN group was higher than those in CTL group, and the expression of rno-miR-24, rno-miR-300-3c was lower (P < 0.05). And the expression of rno-miR-24 and rno-miR-300-3c in MMF group was higher than those in ADN group, and the expression of rno-miR-23a, rno-miR-300-3p was lower (P < 0.05). Conclusions There are significant evidences that mycophenolate mofetil would attenuate podocyte damage in rats with adriamycin nephropathy by regulating miRNAs on chromosome 6 and 19.